DOCSLIB.ORG

Compositions Comprising Pantothenic Acid Or Derivatives Thereof and Their

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Compositions Comprising Pantothenic Acid Or Derivatives Thereof and Their (19) & (11) EP 2 311 448 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 20.04.2011 Bulletin 2011/16 A61K 31/197 (2006.01) A61P 1/00 (2006.01) (21) Application number: 10186192.0 (22) Date of filing: 24.12.2004 (84) Designated Contracting States: (72) Inventor: Hageman, Robert Johan Joseph AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 6705 CT, Wageningen (NL) HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR (74) Representative: Swinkels, Bart Willem (30) Priority: 24.12.2003 EP 03079190 Nederlandsch Octrooibureau J. W. Frisolaan 13 (62) Document number(s) of the earlier application(s) in 2517 JS Den Haag (NL) accordance with Art. 76 EPC: 08163489.1 / 2 002 830 Remarks: 04808826.4 / 1 699 447 This application was filed on 01-10-2010 as a divisional application to the application mentioned (71) Applicant: N.V. Nutricia under INID code 62. 2712 HM Zoetermeer (NL) (54) Compositions comprising pantothenic acidor derivatives thereof and their use for stimulating appetite (57) The present invention relates to the field of food compositions. In particular compositions comprising at least 15 En% protein and pantothenic acid, or equivalents thereof, are provided, which are suitable for stimulating appetite. 48 A1 4 11 11 3 EP 2 Printed by Jouve, 75001 PARIS (FR) 1 EP 2 311 448 A1 2 Description source but which is devoid of pantothenic acid, benefit from the administration of pantothenic acid in terms of Field of the invention incease in weight and of food intake. The authors con- cluded however that there was no relation between level [0001] The present invention relates to the field of food 5 of pantothenic acid and food intake and that pantothenic compositions and their use. In particular compositions acid does not have an influence on growth which is re- comprising pantothenic acid, or equivalents thereof, are lated to appetite. Moreover, no relation is made to a po- provided, which are suitable for stimulating appetite. tential beneficial effect in human patients that have a completely different taste perception and especially no Background of the invention 10 relation is made to human beings that suffer from terminal cancer, AIDS, COPD or other severe disorders. [0002] Pantothenic acid is a water- soluble vitamin, al- [0004] EP 0914111 relates to methods and nutritional so known as vitamin B5, which is a component of coen- compositions for the prevention and treatment of cachex- zyme A (CoA). Pantothenic acid is found in a large range ia and anorexia. In this document there is no suggestion of foods, such as fish, meat, eggs, milk products and15 of a beneficial effect of pantothenic acid to appetite, nor vegetables, as a result of which natural deficiency is very was indicated that the amount of saturated fatty acids, in rarely observed in humans. In the past studies have been particular myristic acid is of any relevance. carried out in which pantothenic acid deficiency has been [0005] DE 4304394 concerns preparations for enteral induced experimentally in humans by administration of feeding of oncologic patients to overcome problems re- a pantothenic acid deficient diet (e.g. Fry et al. 1976, J. 20 lated to weight loss. The preparations are characterised Nutr. Sci. Vitamology 22, 339-346) and/or a compound by a balanced composition of specific types of fats. Also like omega-methyl pantothenic acid which is known to preparations are disclosed that include calcium pantoth- exhibit an anti-pantothenic acid-like effect (see e.g. enate and pantothenic acid but no relation between the Hodges et al. 1959, J. Clin. Invest. 38, 1421-1425). level of pantothenic acid and stimulating appetite was Symptoms exhibited by the participants of such trials25 mentioned or suggested. were gastrointestinal complaints (nausea, vomiting, ab- [0006] Several documents such as DE 29916231, JP dominal cramps), irritability, restlessness, fatigue, apa- 5294833 and US 6322821 describe multivitamin compo- thy, malaise, headache, insomnia, numbness or tingling sitions including calcium pantothenate that are useful to of feet and hands, parasthesia, muscle cramps, stagger- treat amongst others loss of appetite in humans and ing gait, hypoglycaemia and increased sensitivity to in- 30 cows. Neither of these documents however disclose a sulin (see e.g. Hodges et al. 1958, J. Clin. Invest. 37, critical role for the level of pantothenic acid in the com- 1642-1657; Report "Expert Group on Vitamins and Min- positions. No recommended dietary allowance (RDA) for erals 2003" published by the Food Standards Agency, pantothenic acid intake has been set by the Food and AviationHouse, 125 Kingsway, LondonWC2B 6NH, UK). Nutrition Board of the Institute of Medicine (Eissenstat et In other studies, where humans were on a pantothenic 35 al. 1986, Am. J. Clin. Nutr. 44(6), 931-937). Instead, only acid free diet, no clinical signs of deficiency developed approximate adequate daily dietary intake values (AI) (Fry et al. 1976, J. Nutr. Sci. Vitminol. 22(4), 339-346. It have been described for different age or target groups, is concluded that none of the above studies reveal that ranging from 1.7 mg/day in infants to 4-5 mg/day in adults pantothenic acid deficiency is related to the loss of ap- and 6-7 mg/day in pregnant or breastfeeding women (De- petite or that pantothenic acid can be used to restore40 partment of Health, 1991, In: Dietary reference values appetite loss. These studies neither reveal that pan- for food, energy and nutrients for the United Kingdom. tothenic acid can be used to restore bodyweight. It is HMSO, London, p113-115). Also, no tolerable upper lev- particularly noted that increased demands for pantothen- el for pantothenic acid has been set, as there seems to ic acid have never been associated with severe illnesses be no adverse effect of consumption of large amounts. such as cancer, AIDS, catabolism as a result of respira- 45 The only reported adverse effect described is the occur- tory diseases such as lung emphysema, severe traumata rence of diarrhea, associated with intake of 10-20 mg such as surgery and severe diarrhea such as for instance calcium D-pantothenate per day (Flodin 1988, Pharma- occurring with inflammatory bowel disease. In other cology of micronutrients; New York, Alan R. Liss, Inc.). words it is generally not believed that bad appetite and The UK Council for Responsible Nutrition has recom- weight loss associated with any severe illness is caused 50 mended an Upper Safe Level of pantothenic acid of 1000 by a pantothenic acid deficiency. mg/day for long and short term supplementation (leaflet [0003] Vaughan and Vaughan (J. Nutrition, (1960) 70: CRN 1999, The safe use of supplements benefit good 77-80) described the effect of cold on weight, food intake health). and acetylating acitivity of pantothenic acid deficient rats. [0007] Apart from dietary pantothenic acid uptake, They present some data from which it may derived that 55 bacteria colonising the colon are also able to produce healthy rats, that are brought in a pantothenic acid-defi- pantothenic acid, and it is therefore feasible that the pan- cient state by feeding for 33 days an artificial diet that tothenic acid produced in the subject’s intestine is ad- uses casein as protein source and vegetable oil as lipid sorbed and provides a further source of this vitamin (Said 2 3 EP 2 311 448 A1 4 et al. 1998, Am. J. Physiol. 275:C1365-1371). However, inclusion thereof is avoided in the state of the art. Instead it is not known whether internally produced pantothenate corn oil, rapeseed oil, sunflower or soybean oil are in- contributes in significant amounts to the body’s overall cluded which form homogeneous emulsions in complete pantothenate levels. In experimental set- ups, the internal formulae and comprise <0.5% myristic acid. These also bacterial production of pantothenic acid often necessi- 5 comprise high amounts of linoleic acid which is consid- tates treatment with antibiotics in order to elicit pan- ered highly desirable. tothenic acid deficiency in test animals (Stein and Dia- mond 1989, J. Nutr. 119(12), 1973-1983). Detailed description of the invention [0008] Commercially available vitamin supplements mostly also contain pantothenic acid, or derivatives10 Definitions thereof, such as calcium pantothenate, sodium pantoth- enate or panthenol, which are more stable than pan- [0012] "Pantothenic acid" or "pantothenate" or"vitamin tothenic acid. Mostly the D-isomer is used, although DL- B5" refers to a pantoic acid moiety amide linked to a beta- racemic mixtures may also be used. Pantothenate, which alanine subunit (pantoyl beta-alanine). This definition is is taken up with the diet, is adsorbed in the intestine and 15 limited to the active stereoisomer of pantothenate, name- transported via the blood (primarily as bound forms within ly the D- isomers of pantothenate. erythrocytes) to various body tissues. The majority of tis- [0013] "Pantothenic acid derivatives" or "pantothenic sues import pantothenic acid from the blood via an active acid equivalents" is used herein to refer to compounds sodium-dependent co-transport mechanism. Blood plas- derived from pantothenic acid and which have an equiv- ma levels of pantothenic acid have not been found to20 alent or improved appetite stimulating effect as that of correlate well with dietary intake levels, while a good cor- pantothenic acid, such as but not limited to: salts (e.g. relation between urinary excretion of pantothenate and calcium pantothenate, sodium pantothenate), esters or dietary intake has been found (Eissenstat et al. 1986, ethers of pantothenic acid; pantothenol (or panthenol, American J. of Clinical Nutrition 44, 931-937). pantothenyl alcohol); (R)-pantoate or its salts, esters or [0009] Dietary pantothenic acid supplements have25 ethers; pantetheine (pantothenic acid linked to a beta- been proposed to have a beneficial effect in the treatment mercaptoethylamine group) or its salts, esters or ethers, of obesity.
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2013/0034530 A1 Fantz (43) Pub
    US 2013 0034530A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0034530 A1 Fantz (43) Pub. Date: Feb. 7, 2013 (54) DIETARY SUPPLEMENT COGNITIVE (52) U.S. Cl. ....................................... 424/94.2; 424/643 SUPPORT SYSTEM (57) ABSTRACT (75) Inventor: David Robert Fantz, Denver, CO (US) The present invention relates to a nutritional Supplement composition, comprising a therapeutically effective amounts of Vitamin C, Vitamin D3. Thiamin, Riboflavin, Niacin, Vita (73) Assignee: David R. Fantz, Denver, CO (US) min B6, Folic acid, Vitamin B12, Pantothenic acid, Calcium, Magnesium, Zinc, Chromium, Sugar, Protein, Acetyl-L-Car (21) Appl. No.: 13/456,287 nitine, Dimethylaminoethanol complex, Phosphatidylserine complex, L-Glutamine, N-Acetyl-L-Tyrosine, L-Phenylala nine, Taurine, Methionine, Valine, Isoleucine, 5 Hydrox (22) Filed: Apr. 26, 2012 ytryptophan, L-Taurine, N-Acetyl-Tyrosine, N-Acetyl-L- Cysteine, Alpha Lipoic Acid, Alpha Related U.S. Application Data Glycerylphosphoricholine complex, Bacopa Monnieri extract, Gingko Biloba extract, Passion flower, Lemon Balm, (60) Provisional application No. 61/480.372, filed on Apr. Gotu Kola, Ashwagandha, Choline Bitartrate complex, Panax 29, 2011. Ginseng extract, Turmeric, Organic freeze dried fruit juice blends (concord grape, red raspberry, pineapple, cranberry, Publication Classification acai, pomegranate, acerola cherry, bilberry, lingonberry, black currant, aronia, Sour cherry, black raspberry), Organic (51) Int. Cl. freeze dried greens blends (barley grass, broccoli, beet, car A6 IK33/30 (2006.01) rot, alfalfa, oat), and Protein digestive enzyme blends (Pro A6IP3/02 (2006.01) tease 4.5, peptidase, bromelain, protease 6.0, protease 3.0, L A6IP 25/00 (2006.01) planatrum, B bifidum) in a mixture to provide optimal cog A6 IK38/54 (2006.01) nitive function.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110449 A1 Lorber Et Al
    US 200601 10449A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110449 A1 LOrber et al. (43) Pub. Date: May 25, 2006 (54) PHARMACEUTICAL COMPOSITION Publication Classification (76) Inventors: Richard R. Lorber, Scotch Plains, NJ (US); Heribert W. Staudinger, Union, (51) Int. Cl. NJ (US); Robert E. Ward, Summit, NJ A6II 3/473 (2006.01) (US) A6II 3L/24 (2006.01) Correspondence Address: A6IR 9/20 (2006.01) SCHERING-PLOUGH CORPORATION (52) U.S. Cl. ........................... 424/464; 514/290: 514/540 PATENT DEPARTMENT (K-6-1, 1990) 2000 GALLOPNG HILL ROAD KENILWORTH, NJ 07033-0530 (US) (57) ABSTRACT (21) Appl. No.: 11/257,348 (22) Filed: Oct. 24, 2005 The present invention relates to formulations useful for Related U.S. Application Data treating respiratory disorders associated with the production of mucus glycoprotein, skin disorders, and allergic conjunc (60) Provisional application No. 60/622,507, filed on Oct. tivitis while substantially reducing adverse effects associ 27, 2004. Provisional application No. 60/621,783, ated with the administration of non-selective anti-cholin filed on Oct. 25, 2004. ergic agents and methods of use thereof. US 2006/01 10449 A1 May 25, 2006 PHARMACEUTICAL COMPOSITION example, Weinstein and Weinstein (U.S. Pat. No. 6,086,914) describe methods of treating allergic rhinitis using an anti CROSS REFERENCE TO RELATED cholinergic agent with a limited capacity to pass across lipid APPLICATION membranes, such as the blood-brain barrier, in combination with an antihistamine that is limited in both sedating and 0001. This application claims benefit of priority to U.S.
    [Show full text]
  • Optimal Foods
    Optimal Foods 1. Almonds: high in monounsaturated and polyunsaturated fats, with 20% of calories coming from protein and dietary fiber. Nutrients include potassium, magnesium, calcium, iron, zinc, vitamin E and an antioxidant flavonoid called amygdlin also known as laetrile. 2. Barley: Like oat bran it is high in beta-glucan fiber which helps to lower cholesterol. Nutrients include copper, magnesium, phosphorous and niacin. 3. Berries : The darker the berry the higher in anti-oxidants. Nutritionally they are an excellent source of flavonoids, especially anthocyanidins, vitamin C and both soluble and insoluble fiber. 4. Brussels Sprouts : Similar to broccoli, and a member of the cabbage family, it contains cancer fighting glucosinolates. Nutritionally it is an excellent source of vitamin C and K, the B vitamins, beta-carotene, potassium and dietary fiber. 5. Carrots: It contains the highest source of proviatamin A carotenes as well as vitamin K, biotin, vitamin C, B6, potassium, thiamine and fiber. 6. Dark Chocolate: It is rich in the flavonoids, similar to those found in berries and apples, that are more easily absorbed than in other foods. It also provides an amino acid called arginine that helps blood vessels to dilate hence regulating blood flow and helping to lower blood pressure. Choose high-quality semisweet dark chocolate with the highest cocoa content that appeals to your taste buds. 7. Dark leafy greens : Kale, arugula, spinach, mustard greens, chard, collards, etc: low calorie, anti-oxidant dense food with carotenes, vitamin C, folic acid, manganese, copper, vitamin E, copper, vitamin B6, potassium, calcium, iron and dietary fiber. Kale is a particularly excellent bioavailable source of calcium while spinach is not.
    [Show full text]
  • Toxicological and Pharmacological Profile of Amanita Muscaria (L.) Lam
    Pharmacia 67(4): 317–323 DOI 10.3897/pharmacia.67.e56112 Review Article Toxicological and pharmacological profile of Amanita muscaria (L.) Lam. – a new rising opportunity for biomedicine Maria Voynova1, Aleksandar Shkondrov2, Magdalena Kondeva-Burdina1, Ilina Krasteva2 1 Laboratory of Drug metabolism and drug toxicity, Department “Pharmacology, Pharmacotherapy and Toxicology”, Faculty of Pharmacy, Medical University of Sofia, Bulgaria 2 Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, Bulgaria Corresponding author: Magdalena Kondeva-Burdina ([email protected]) Received 2 July 2020 ♦ Accepted 19 August 2020 ♦ Published 26 November 2020 Citation: Voynova M, Shkondrov A, Kondeva-Burdina M, Krasteva I (2020) Toxicological and pharmacological profile of Amanita muscaria (L.) Lam. – a new rising opportunity for biomedicine. Pharmacia 67(4): 317–323. https://doi.org/10.3897/pharmacia.67. e56112 Abstract Amanita muscaria, commonly known as fly agaric, is a basidiomycete. Its main psychoactive constituents are ibotenic acid and mus- cimol, both involved in ‘pantherina-muscaria’ poisoning syndrome. The rising pharmacological and toxicological interest based on lots of contradictive opinions concerning the use of Amanita muscaria extracts’ neuroprotective role against some neurodegenerative diseases such as Parkinson’s and Alzheimer’s, its potent role in the treatment of cerebral ischaemia and other socially significant health conditions gave the basis for this review. Facts about Amanita muscaria’s morphology, chemical content, toxicological and pharmacological characteristics and usage from ancient times to present-day’s opportunities in modern medicine are presented. Keywords Amanita muscaria, muscimol, ibotenic acid Introduction rica, the genus had an ancestral origin in the Siberian-Be- ringian region in the Tertiary period (Geml et al.
    [Show full text]
  • The Effect of Vitamin Supplementation on Subclinical
    molecules Review The Effect of Vitamin Supplementation on Subclinical Atherosclerosis in Patients without Manifest Cardiovascular Diseases: Never-ending Hope or Underestimated Effect? Ovidiu Mitu 1,2,* , Ioana Alexandra Cirneala 1,*, Andrada Ioana Lupsan 3, Mircea Iurciuc 4 , 5 5 2, Ivona Mitu , Daniela Cristina Dimitriu , Alexandru Dan Costache y , Antoniu Octavian Petris 1,2 and Irina Iuliana Costache 1,2 1 Department of Cardiology, Clinical Emergency Hospital “Sf. Spiridon”, 700111 Iasi, Romania 2 1st Medical Department, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania 3 Department of Cardiology, University of Medicine, Pharmacy, Science and Technology, 540139 Targu Mures, Romania 4 Department of Cardiology, University of Medicine and Pharmacy “Victor Babes”, 300041 Timisoara, Romania 5 2nd Morpho-Functional Department, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania * Correspondence: [email protected] (O.M.); [email protected] (I.A.C.); Tel.: +40-745-279-714 (O.M.) Medical Student, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania. y Academic Editors: Raluca Maria Pop, Ada Popolo and Stefan Cristian Vesa Received: 25 March 2020; Accepted: 7 April 2020; Published: 9 April 2020 Abstract: Micronutrients, especially vitamins, play an important role in the evolution of cardiovascular diseases (CVD). It has been speculated that additional intake of vitamins may reduce the CVD burden by acting on the inflammatory and oxidative response starting from early stages of atherosclerosis, when the vascular impairment might still be reversible or, at least, slowed down. The current review assesses the role of major vitamins on subclinical atherosclerosis process and the potential clinical implications in patients without CVD.
    [Show full text]
  • DRIDIETARY REFERENCE INTAKES Thiamin, Riboflavin, Niacin, Vitamin
    Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline http://www.nap.edu/catalog/6015.html DIETARY REFERENCE INTAKES DRI FOR Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline A Report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients Food and Nutrition Board Institute of Medicine NATIONAL ACADEMY PRESS Washington, D.C. Copyright © National Academy of Sciences. All rights reserved. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline http://www.nap.edu/catalog/6015.html NATIONAL ACADEMY PRESS • 2101 Constitution Avenue, N.W. • Washington, DC 20418 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This project was funded by the U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion, Contract No. 282-96-0033, T01; the National Institutes of Health Office of Nutrition Supplements, Contract No. N01-OD-4-2139, T024, the Centers for Disease Control and Prevention, National Center for Chronic Disease Preven- tion and Health Promotion, Division of Nutrition and Physical Activity; Health Canada; the Institute of Medicine; and the Dietary Reference Intakes Corporate Donors’ Fund.
    [Show full text]
  • Safety Assessment of Panthenol, Pantothenic Acid, and Derivatives As Used in Cosmetics
    Safety Assessment of Panthenol, Pantothenic Acid, and Derivatives as Used in Cosmetics Status: Scientific Literature Review for Public Comment Release Date: February 2, 2017 Panel Meeting Date: April 10-11, 2017 All interested persons are provided 60 days from the above date to comment on this safety assessment and to identify additional published data that should be included or provide unpublished data which can be made public and included. Information may be submitted without identifying the source or the trade name of the cosmetic product containing the ingredient. All unpublished data submitted to CIR will be discussed in open meetings, will be available at the CIR office for review by any interested party and may be cited in a peer-reviewed scientific journal. Please submit data, comments, or requests to the CIR Director, Dr. Lillian J. Gill. The 2017 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D., Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This safety assessment was prepared by Laura N. Scott, Scientific Writer/Analyst. © Cosmetic Ingredient Review 1620 L Street, NW, Suite 1200 ♢ Washington, DC 20036-4702 ♢ ph 202.331.0651 ♢ fax 202.331.0088 ♢ [email protected] INTRODUCTION This assessment reviews the safety of Panthenol, Pantothenic Acid and 5 of their derivatives as used in cosmetic formulations.
    [Show full text]
  • LYSOVIT® (B-Complex+Lysine)
    Lysovit/LPD/PK-02 LYSOVIT® (B-Complex+Lysine) 1. NAME OF THE MEDICINAL PRODUCT LYSOVIT® 2. QUALITATIVE AND QUANTITATIVE COMPOSITION LYSOVIT® Syrup 120 ml Description Each 5 ml contains: Thiamine HCl 4.16 mg Riboflavin USP 1.66 mg Pyridoxine HCl 1 mg Niacinamide USP 18 mg D-Panthenol USP 2.5 mg Cyanocobalamin USP 8.33 mcg Ascorbic Acid USP 75 mg Inositol USP 5 mg Lysine Monohydrochloride USP 33.33 mg 3. PHARMACEUTICAL FORM Syrup 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS 1. For maintenance of health and to meet the extra energy needs of growing children. 2. Increases appetite and helps in recovery from illnesses. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Children: 1 teaspoonful daily or as prescribed by the physician Adults: One to two teaspoonsful daily. Shake well before use. Thiamine Benefits: Thiamine is recommended for digestive problems including poor appetite, ulcerative colitis, and ongoing diarrhea. People take thiamine for conditions related to low levels of thiamine (thiamine deficiency syndromes), including beriberi and inflammation of the nerves (neuritis) associated with pellagra or pregnancy.4 1 Lysovit/LPD/PK-02 Thiamine - Daily Recommended Dietary Allowance (RDA): In adults, 1-2 mg of thiamine per day is commonly used. Infants 0-6 months, 0.2 mg Infants 7-12 months, 0.3 mg Children 1-3 years, 0.5 mg Children 4-8 years, 0.6 mg Boys 9-13 years, 0.9 mg Men 14 years and older, 1.2 mg4 Girls 9-13 years, 0.9 mg Women 14-18 years, 1 mg Women over 18 years, 1.1 mg Pregnant women, 1.4 mg Breast-feeding women, 1.5 mg Riboflavin Benefits: Riboflavin had a direct impact on maintenance of good brain function.
    [Show full text]
  • Water-Soluble Vitamins: B-Complex and Vitamin C Fact Sheet No
    Water-Soluble Vitamins: B-Complex and Vitamin C Fact Sheet No. 9.312 Food and Nutrition Series|Health by L. Bellows and R. Moore* What are Vitamins? and their influence is felt in many parts of Quick Facts Vitamins are essential nutrients found the body. They function as coenzymes that • B-complex vitamins and in foods. They perform specific and vital help the body obtain energy from food. The vitamin C are water-soluble functions in a variety of body systems, and B vitamins are also important for normal are crucial for maintaining optimal health. appetite, good vision, and healthy skin, vitamins that are not stored The two different types of vitamins nervous system, and red blood cell formation. in the body and must be are fat-soluble vitamins and water-soluble Thiamin: Vitamin B1 replaced each day. vitamins. Fat-soluble vitamins — vitamins What is Thiamin. Thiamin, or vitamin B1, • These vitamins are easily A, D, E and K — dissolve in fat before they helps to release energy from foods, promotes destroyed or washed out are absorbed in the bloodstream to carry out normal appetite, and is important in during food storage and their functions. Excesses of these vitamins maintaining proper nervous system function. are stored in the liver, and are not needed Food Sources for Thiamin. Sources preparation. every day in the diet. For more information include peas, pork, liver, and legumes. Most • The B-complex group is on fat-soluble vitamins, see fact sheet 9.315 commonly, thiamin is found in whole grains found in a variety of foods: Fat-Soluble Vitamins: A, D, E, and K.
    [Show full text]
  • Nutrition in Addiction Recovery
    Many Hands Sustainability Center 411 Sheldon Road Barre, MA 01005 http://manyhandssustainabilitycenter.org Nutrition in Addiction Recovery by Rebecca Place Miller, Science Writer May 2010 Table of Contents I. Introduction II. What is Addiction? III. Addiction in the Brain Neurotransmitters: Chemical Messengers An Imbalanced Brain Recovery Foods for Neurotransmitters Summary of Abused Substances and Health Problems IV. Addiction in the Body Hypoglycemia Adrenal Fatigue Allergies/Sensitivities Leaky Gut Yeast/Candida Problems V. Common Nutritional Deficiencies Carbohydrates Protein Fats Vitamins and Minerals Nutritional Supplements VI. Eating in Recovery What to Eat What Not to Eat When to Eat Can Food Work in Recovery? VII. List of Resources VIII. References 1 I. Introduction Making the connection between addiction and nutrition: a literature review. This document has been prepared by Many Hands Sustainability Center (MHSC) as part of its Nutritional Many Hands Sustainability Center, Education and Job-Training Program, a program that located in Barre, Massachusetts, is a nonprofit educational center estab- offers former prisoners recovering from drug and lished in 2007 to educate about alcohol addiction an opportunity to develop job skills, sustainable living, organic farming, learn about all aspects of organic farming, and become and good nutrition. The Center is an educated about proper nutrition and healthier lifestyle outgrowth of Many Hands Organic choices. Farm, which since 1984 has offered over 300 educational workshops on food/nutrition and organic farming This document has been prepared to educate people and has helped launch a number of about how drugs and alcohol can disrupt the normal successful farm education programs functioning of the body and how better nutrition can across Massachusetts.
    [Show full text]
  • 021876Orig1s000
    CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 021876Orig1s000 PHARMACOLOGY REVIEW(S) MEMO FOOD AND DRUG ADMINISTRATION Division of Reproductive and Urologic Products Center for Drug Evaluation and Research Date: April 5, 2013 From: Kimberly Hatfield, Ph.D. Toxicologist To: NDA 21876 Subject: Changes to nonclinical scientific bridge and labeling for NDA 21876 (Diclegis) Scientific bridge: NDA 21876 has been submitted as a 505(b)(2) application for the drug product Diclegis (combination of doxylamine succinate and pyridoxine hydrochloride), with nonclinical evidence supporting the safety of Diclegis being based on the Agency’s determination of safety for the Reference Listed Drug (RLD), Bendectin® (NDA 10-598). The nonclinical scientific bridge between Diclegis and the RLD Bendectin® has been revised since submission of the initial nonclinical NDA review. It now states: The bridge for reliance on the nonclinical data generated with Bendectin (10 mg doxylamine succinate and 10 mg pyridoxine hydrochloride) to support the NDA for Diclegis (10 mg doxylamine succinate and 10 mg pyridoxine hydrochloride) is based on: 1) in vivo delayed release, 2) similar pharmacodynamic characteristics, and 3) in vitro dissolution based on Diclectin (a Canadian approved drug product containing 10 mg doxylamine succinate and 10 mg pyridoxine hydrochloride) manufactured at (b) (4) and 4) chemical criteria for doxylamine succinate and pyridoxine hydrochloride defined in the US Pharmacopeia e.g., composition, structure, molecular weight and chemical characteristics. Refer also to the clinical pharmacology memo further elaborating on the scientific bridge submitted by CAPT E. Dennis Bashaw, PharmD. Labeling changes: During label negotiations, a change in Section 13 Carcinogenesis, Mutagenesis and Impairment of Fertility was made.
    [Show full text]
  • Nutrition Journal of Parenteral and Enteral
    Journal of Parenteral and Enteral Nutrition http://pen.sagepub.com/ Micronutrient Supplementation in Adult Nutrition Therapy: Practical Considerations Krishnan Sriram and Vassyl A. Lonchyna JPEN J Parenter Enteral Nutr 2009 33: 548 originally published online 19 May 2009 DOI: 10.1177/0148607108328470 The online version of this article can be found at: http://pen.sagepub.com/content/33/5/548 Published by: http://www.sagepublications.com On behalf of: The American Society for Parenteral & Enteral Nutrition Additional services and information for Journal of Parenteral and Enteral Nutrition can be found at: Email Alerts: http://pen.sagepub.com/cgi/alerts Subscriptions: http://pen.sagepub.com/subscriptions Reprints: http://www.sagepub.com/journalsReprints.nav Permissions: http://www.sagepub.com/journalsPermissions.nav >> Version of Record - Aug 27, 2009 OnlineFirst Version of Record - May 19, 2009 What is This? Downloaded from pen.sagepub.com by Karrie Derenski on April 1, 2013 Review Journal of Parenteral and Enteral Nutrition Volume 33 Number 5 September/October 2009 548-562 Micronutrient Supplementation in © 2009 American Society for Parenteral and Enteral Nutrition 10.1177/0148607108328470 Adult Nutrition Therapy: http://jpen.sagepub.com hosted at Practical Considerations http://online.sagepub.com Krishnan Sriram, MD, FRCS(C) FACS1; and Vassyl A. Lonchyna, MD, FACS2 Financial disclosure: none declared. Preexisting micronutrient (vitamins and trace elements) defi- for selenium (Se) and zinc (Zn). In practice, a multivitamin ciencies are often present in hospitalized patients. Deficiencies preparation and a multiple trace element admixture (containing occur due to inadequate or inappropriate administration, Zn, Se, copper, chromium, and manganese) are added to par- increased or altered requirements, and increased losses, affect- enteral nutrition formulations.
    [Show full text]